If tirzepatide remains ineffective despite optimization of all modifiable factors, alternative GLP-1 receptor agonists or other weight management medications may be considered
Their concerns center on several issues
Murvelashvili N, Xie L, Schellinger JN, Mathew MS, Marroquin EM, Lingvay I, et al
They found treatment with semaglutide/trizepatide improved body composition by reducing excess body fat, including abdominal fat, and increasing the proportion of lean body mass, or the amount of weight someone carries that is not body fat
This commitment to quality and high standards provides researchers with confidence in their products
Bonus: Portable for early morning meetings or when you need to eat breakfast at your desk